Abstract
This chapter presents a series of multiple choice questions and answers on prognostic markers and management of chronic lymphocytic leukemia (CLL). It commences with a discourse on "classical" prognostic factors, which are associated with improved survival in CLL, and ends with the patient's high-risk features that affects the treatment decision. The chapter also discusses on the molecular results that are associated with an inferior prognosis in CLL, the agents that is the most appropriate for first-line therapy, and the best next step in CLL management.
| Original language | English (US) |
|---|---|
| Title of host publication | Cancer Consult |
| Subtitle of host publication | Expertise for Clinical Practice |
| Publisher | Wiley-Blackwell |
| Pages | 193-200 |
| Number of pages | 8 |
| ISBN (Electronic) | 9781118589199 |
| ISBN (Print) | 9781118589212 |
| DOIs | |
| State | Published - Jun 20 2014 |
Keywords
- Chronic lymphocytic leukemia (CLL)
- First-line therapy
- Prognostic markers
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Prognostic Markers and Management of Chronic Lymphocytic Leukemia'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS